Pentagon to proceed with controversial testosterone testing after pause
The Hindu – International
You are logged in
Loading…
You don’t have any Active Subscription.
Subscribed with another email? Logout and Login with that one.
Your active subscription(s)
Account subscription benefits alongside Premium Stories, Editorials,
Opinions and more. Unlock these with Subscription
Products you’ve access to
Additional Subscription Benefits
Account Settings
Need help with your subscription?
Weather News September 18, 2026 e-Paper
The View From India
Looking at World Affairs from the Indian perspective.
First Day First Show
News and reviews from the world of cinema and streaming.
Today's Cache
Your download of the top 5 technology stories of the day.
Science For All
The weekly newsletter from science writers takes the jargon out of science and puts the fun in!
Data Point
Decoding the headlines with facts, figures, and numbers
THEdge
At the cutting edge of education and careers
Health Matters
Ramya Kannan writes to you on getting to good health, and staying there
Gender Agenda
Stories from beyond the binary.
The Hindu On Books
Books of the week, reviews, excerpts, new titles and features.
Weather News September 18, 2026 e-Paper
Published – September 18, 2026 09:45 am IST – WASHINGTON
U.S. Secretary of Defense Pete Hegseth. File
| Photo Credit: Reuters
The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among U.S. service members aged 30 and older, a spokesperson said on Thursday (September 17, 2026), bringing back a program that many medical experts have described as unnecessary and potentially harmful.
U.S. Defence Secretary Pete Hegseth, who has promoted the use of testosterone to improve military readiness, first announced the screening mandate in July.
Under the announced guidance, women were also set to be screened through a questionnaire and could then move to treatment for conditions related to hormonal imbalances.
In early September, however, the Pentagon temporarily rescinded the published medical guidance for the testosterone screening “to allow for updates.”
The latest move lifts that pause, allowing testing to go forward. It was not immediately clear what, if any, updates had been made to the original policy.
“Effective immediately, this guidance addresses male testosterone deficiency, establishing uniform screening and treatment pathways,” Pentagon spokesperson Sean Parnell said in a statement.
Medical professionals have warned that testosterone, if prescribed inappropriately, could increase service members’ risk of infertility or lead to other health consequences.
Published – September 18, 2026 09:45 am IST
Copyright© 2026, THG PUBLISHING PVT LTD. or its affiliated companies. All rights reserved.
BACK TO TOP
Terms & conditions | Institutional Subscriber
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
Fonte: The Hindu – International
